The Health Policy Track marks the start of a new five-year political cycle in the EU. Featuring numerous European Commission officials on the panels and podium, it will provide valuable and exclusive insights for the coming period. It also offers the opportunity for key policymakers to make timely inputs into various areas of pharmaceutical legislation, such as orphan medicines, pharmaceuticals in the environment, HTA regulation and pricing and transparency.
Who is This Track Designed For?
Public affairs, governmental affairs and policy specialists, corporate affairs and communications professionals, consultants, lawyers and legal consultants, MEP assistants, trade association representatives, political advisors and aides and organisations involved in pharmaceutical and health policy.